Finance

Lists
Why is CRTX down 5.56%?
Dive Deeper
CRTX:LON
CRISM' Therapeutics Corp
GBX 8.50
-5.56%
(-0.50) 1D
Oct 19, 4:30:00 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for CRTX...
Open
GBX 9.50
High
GBX 9.50
Low
GBX 8.50
Mkt. cap
6.73M
Avg. vol.
79.56K
Volume
3.97K
52-wk high
GBX 18.50
52-wk low
GBX 8.00
EPS
-GBX 0.05
Shares outstanding
79.19M
No. of employees
0
Open
GBX 9.50
High
GBX 9.50
Low
GBX 8.50
Mkt. cap
6.73M
Avg. vol.
79.56K
Volume
3.97K
52-wk high
GBX 18.50
52-wk low
GBX 8.00
EPS
-GBX 0.05
Shares outstanding
79.19M
No. of employees
0
News stories
From web sources and news partners
About CRISM' Therapeutics Corp
CEORobin J. Young
Employees0
Founded2016
Headquarters-
SectorBiotechnology
Websitecrismtherapeutics.com
Previous reports
Loading Previous Earnings...
Revenue
Net income
All values in GBP
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
115.50K
115.50K
60.50K
60.50K
Cost of goods sold
48.50K
48.50K
14.50K
14.50K
Cost of revenue
48.50K
48.50K
14.50K
14.50K
Research and development expenses
454.00K
454.00K
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
73.50K
73.50K
760.00K
760.00K
Operating expense
552.00K
552.00K
760.00K
760.00K
Total operating expenses
600.50K
600.50K
774.50K
774.50K
Operating income
-485.00K
-485.00K
-714.00K
-714.00K
Other non operating income
-
-
-
-
EBT including unusual items
-485.00K
-485.00K
-714.00K
-714.00K
EBT excluding unusual items
-485.00K
-485.00K
-714.00K
-714.00K
Income tax expense
-1.00K
-1.00K
-5.00K
-5.00K
Effective tax rate
0.21%
0.21%
0.70%
0.70%
Other operating expenses
16.00K
16.00K
-
-
Net income
-486.50K
-486.50K
-706.50K
-706.50K
Net profit margin
-421.21%
-421.21%
-1,167.77%
-1,167.77%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
8.50K
8.50K
-
-
EBITDA
-480.50K
-480.50K
-709.50K
-709.50K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps